SEC 13F Intelligence

Adams Diversified Equity Fund, Inc. / REGN

Adams Diversified Equity Fund, Inc.’s Regeneron Pharmaceuticals Position

Does Adams Diversified Equity Fund, Inc. own Regeneron Pharmaceuticals (REGN)? Not currently — the last reported position was 19.7K shares worth $10M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$10M
Q2 2025
Shares
19.7K
% of Portfolio
+0.37%
Quarters Held
16
position exited

Position History REGN

Reported value by quarter
Q3 ’21: $18MQ3 ’21Q4 ’21: $19MQ1 ’22: $31MQ1 ’22Q2 ’22: $18MQ3 ’22: $21MQ3 ’22Q4 ’22: $24MQ1 ’23: $28MQ1 ’23Q2 ’23: $14MQ3 ’23: $27MQ3 ’23Q4 ’23: $28MQ1 ’24: $31MQ1 ’24Q2 ’24: $34MQ3 ’24: $23MQ3 ’24Q4 ’24: $15MQ1 ’25: $12MQ1 ’25Q2 ’25: $10Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 202519.7K$10M+0.37%
Q1 202519.7K$12M+0.50%
Q4 202421.7K$15M+0.58%
Q3 202421.7K$23M+0.84%
Q2 202432.3K$34M+1.16%
Q1 202432.3K$31M+1.10%
Q4 202332.3K$28M+1.12%
Q3 202332.3K$27M+1.14%
Q2 202320.0K$14M+0.60%
Q1 202333.5K$28M+1.24%
Q4 202233.5K$24M+1.16%
Q3 202230.6K$21M+1.05%
Q2 202230.6K$18M+0.86%
Q1 202245.0K$31M+1.25%
Q4 202130.1K$19M+0.72%
Q3 202130.1K$18M+0.72%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Adams Diversified Equity Fund, Inc.’s full portfolio or all institutional holders of REGN.